Onyx Pharmaceuticals (NASDAQ: ONXX) stock declined recently on reports that potential suitor Amgen (Nasdaq: AMGN) may delay its bid. Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE